Oncotarget | CUDC907 Promotes Apoptosis of NF2 Schwannoma Cells
July 26, 2022
CUDC907 has cytotoxic activity in NF2 schwannoma models and primary VS cells and is a candidate for clinical trials.”BUFFALO, NY- July 26, 2022 – A new research paper was... read more